Something to worry about (trial showing drop in efficacy) Waiting for full paper. (Small sample, don't know about severe disease, which is key). Today we also learned Pfizer looks to be effective against that variant. We're gonna need boosters. (Novavax already working on one).https://twitter.com/JBDavis2/status/1354942205291585546 …
-
-
It is terrible. Flights are at historical lows and so are interpersonal contacts, and still the variants are crossing borders and spreading like wildfire. Variants will always prevail. That 90% is completely worthless now. If the vaccine turned out to cause significant>
-
debilitating disease, we'd still be crushed by its weight. After this spring, I'm pretty sure anti-restrictionism could grow to a popularity that will make containment impossible. I've always tried to be optimistic, but this is just the last of a long series of short straws.
- Show replies
New conversation -
-
-
> may well be cutting severe disease significantly (which is what matters most). We'll look at the paper Seems like we really ought to focus on just 2 metrics for vax efficacy vs. all variants: 1) Impact on severe disease 2) Impact on transmission What else matters, really?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.